Publications by authors named "Susan Adakun"

Claim this Profile
P
Performance evaluation of alternative bacteriological measures of response to MDR/RR-TB therapy during the initial 16 weeks of treatment.
Willy Ssengooba, Emmanuel Musisi, Derrick Semugenze, Kevin Komakech, Moses Ndema, Susan Adakun

BMC Infect Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance evaluation of alternative bacteriological measures of response to MDR-TB therapy during the initial 16 weeks of treatment.
Willy Ssengooba, Emmanuel Musisi, Derrick Semugenze, Kevin Komakech, Moses Ndema, Susan Adakun

Res Sq· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuberculosis and diabetes mellitus comorbidity in an adult Ugandan population.
Davis Kibirige, Irene Andia-Biraro, Ronald Olum, Susan Adakun, Stella Zawedde-Muyanja

BMC Infect Dis· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of World Health Organization-defined Severe Respiratory Distress without Shock in Adults in Sub-Saharan Africa.
Bickey H Chang, Susan A Adakun, Mary A Auma, Patrick Banura, Albert Majwala

Am J Respir Crit Care Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic accuracy of two confirmatory tests for diabetes mellitus in adult Ugandans with recently diagnosed tuberculosis.
Davis Kibirige, Stella Zawedde-Muyanja, Irene Andia-Biraro, Ronald Olum, Susan Adakun

Ther Adv Infect Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent pneumothorax in a human immunodeficiency virus-positive patient with multidrug-resistant tuberculosis: a rare case of bronchopleural fistula: a case report.
Lydia Nakiyingi, Joseph Baruch Baluku, Willy Ssengooba, Sharon Miriam Namiiro, Paul Buyego, Susan Adakun

J Med Case Rep· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from Uganda.
Willy Ssengooba, Kevin Komakech, Sharon Namiiro, Henry Byabajungu, Joanitah Nalunjogi, Susan Adakun

J Clin Tuberc Other Mycobact Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discordance of the Repeat GeneXpert MTB/RIF Test for Rifampicin Resistance Detection Among Patients Initiating MDR-TB Treatment in Uganda.
Willy Ssengooba, Jean de Dieu Iragena, Kevin Komakech, Iginitius Okello, Joanitah Nalunjogi, Susan Adakun

Open Forum Infect Dis· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and factors associated with non-adherence to multi-drug resistant tuberculosis (MDR-TB) treatment at Mulago National Referral Hospital, Kampala, Uganda.
Charles Batte, Martha S Namusobya, Racheal Kirabo, John Mukisa, Susan Adakun

Afr Health Sci· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Derivation and validation of a universal vital assessment (UVA) score: a tool for predicting mortality in adult hospitalised patients in sub-Saharan Africa.
Christopher C Moore, Riley Hazard, Kacie J Saulters, John Ainsworth, Susan A Adakun

BMJ Glob Health· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher baseline CD4 cell count predicts treatment interruptions and persistent viremia in patients initiating ARVs in rural Uganda.
Susan A Adakun, Mark J Siedner, Conrad Muzoora, Jessica E Haberer, Alexander C Tsai

J Acquir Immune Defic Syndr· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis